Baker Bros. Advisors’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Baker Bros. Advisors’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-61,424	Closed	-$715K	–	123
2022 Q1	$715K	Hold	61,424	–	–	﹤0.01%	112
2021 Q4	$1.12M	Hold	61,424	–	–	0.01%	114
2021 Q3	$728K	Hold	61,424	–	–	﹤0.01%	120
2021 Q2	$1.06M	Hold	61,424	–	–	﹤0.01%	115
2021 Q1	$1.12M	Hold	61,424	–	–	﹤0.01%	117
2020 Q4	$1.16M	Sell	61,424 -6,804	-10%	-$147K	﹤0.01%	115
2020 Q3	$1.44M	Sell	68,228 -3,200	-4%	-$74.8K	0.01%	107
2020 Q2	$2.06M	Buy	+71,428	New	+$2.15M	0.01%	103

Other funds holding OYST

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

IFA

Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

TAM

Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Baker Bros. Advisors's OYST Position: Q2 2022 in Review

Baker Bros. Advisors sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q2 2022, closing a stake of 61,424 shares — an estimated $715K sold.

Baker Bros. Advisors first reported a position in OYST in Q2 2020 and held it in 8 quarters. The position peaked at $2.06M in Q2 2020. 61 funds tracked by Wall St. Rank hold OYST as of Q2 2022.

Baker Bros. Advisors reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Baker Bros. Advisors sold 61,424 Oyster Point Pharma, Inc. Common Stock shares in Q2 2022, an estimated $715K.
Baker Bros. Advisors first reported a position in Oyster Point Pharma, Inc. Common Stock in Q2 2020 and held it in 8 quarters.
Baker Bros. Advisors's Oyster Point Pharma, Inc. Common Stock position peaked at $2.06M in Q2 2020.
61 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q2 2022.

Based on Baker Bros. Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.